propranolol sandoz 40 mg tablete
sandoz d.o.o., maksimirska 120, zagreb - propranololklorid - tableta - 40 mg - urbroj: jedna tableta sadrži 40 mg propranololklorida
propranolol lek 40 mg/1 tableta tableta
novartis ba d.o.o. - propranolol - tableta - 40 mg/1 tableta - 1 tableta sadrži: 40 mg propranololhidrohlorida
propranolol sandoz 40 mg/1 tableta tableta
sandoz d.o.o. - propranolol - tableta - 40 mg/1 tableta - 1 tableta sadrži: 40 mg propranololhidrohlorida
propranolol 40 mg/1 tableta tableta
galenika d.o.o. - propranolol - tableta - 40 mg/1 tableta - 1 tableta sadrži 40 mg propranololhidrohlorida
propranolol galenika 40 mg/1 tableta tableta
galenika d.o.o. - propranolol - tableta - 40 mg/1 tableta - 1 tableta sadrži 40 mg propranololhidrohlorida
propranolol remedica 40 mg/1 tableta film tableta
farmalogist allbix d.o.o. bijeljina - propranolol - film tableta - 40 mg/1 tableta - 1 film tableta sadrži 40 mg propranololhidrohlorida
hemangiol
pierre fabre medicament - propranolol hidroklorid - hemangiom - beta blokirajuća sredstva - hemangiol is indicated in the treatment of proliferating infantile haemangioma requiring systemic therapy: , life- or function-threatening haemangioma,, ulcerated haemangioma with pain and/or lack of response to simple wound care measures,, haemangioma with a risk of permanent scars or disfigurement. , it is to be initiated in infants aged 5 weeks to 5 months.
fortekor plus
elanco gmbh - benazepril hidroklorid, pimobendan - ace inhibitori, kombinacije - psi - za liječenje kongestivnog zatajenja srca zbog предсердно-желудочковая zatajenje ventila ili дилатационной кардиомиопатии kod pasa.
zeposia
bristol-myers squibb pharma eeig - ozanimod hidroklorid - multiple sclerosis, relapsing-remitting; colitis, ulcerative - imunosupresivi - multiple sclerosiszeposia is indicated for the treatment of adult patients with relapsing remitting multiple sclerosis (rrms) with active disease as defined by clinical or imaging features. ulcerative colitiszeposia is indicated for the treatment of adult patients with moderately to severely active ulcerative colitis (uc) who have had an inadequate response, lost response, or were intolerant to either conventional therapy or a biologic agent.
rhinobos 160 mg/5 ml+ 2.5 mg/5 ml+ 1 mg/5 ml sirup
bosnalijek d.d. - fenilefrin, hlorfenamin, paracetamol - sirup - 160 mg/5 ml+ 2.5 mg/5 ml+ 1 mg/5 ml - 5 ml sirupa sadrži: 160 mg paracetamol 2,5 mg fenilefrinhidrohlorid 1 mg hlorfenaminmaleat